Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals, Inc. | President, CEO, and Chairman, Director | $25.3M | -$457K | -1.78% | Sep 17, 2024 |
ABGI | ABG Acquisition Corp. I | Director | Mar 1, 2023 | |||
KZR | Kezar Life Sciences, Inc. | Director | Jun 28, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|